Multimodal plasma and urinary cell-free DNA profiling improves risk stratification in newly diagnosed prostate cancer. [PDF]
Riediger AL +9 more
europepmc +1 more source
Circulating cell-free DNA as an integrative biomarker in breast cancer: correlation with molecular subtypes, mutation status, and treatment response. [PDF]
Solanki R +5 more
europepmc +1 more source
Cell-free DNA in precision medicine: overcoming biological barriers through integrated nanoparticle platforms for simultaneous diagnosis and therapy. [PDF]
Esfandiari N +4 more
europepmc +1 more source
Machine learning-based cfDNA fragmentation profiling using automated capillary electrophoresis for early detection of hepatocellular carcinoma. [PDF]
Udomruk S +20 more
europepmc +1 more source
Is There an Ace Up One's Sleeve in the Preanalytical Phase of the Circulating Tumor DNA Analysis? [PDF]
de Azevedo Junior JC +7 more
europepmc +1 more source
Cell-free DNA in female infertility: from pathological mechanisms to clinical biomarkers. [PDF]
Lin L, Zhang X, Liu S, Ge H.
europepmc +1 more source
Exploratory biomarkers for acute rejection in vascularized composite allotransplantation. [PDF]
Pullmann D +8 more
europepmc +1 more source
Profiling of human and microbial cell-free DNA reflects early host-pathogen interactions in sepsis. [PDF]
Hoeter K +8 more
europepmc +1 more source
Detection of mutated KRAS, TP53, CDKN2A, and SMAD4 in tumor cell-free DNA of Brazilian pancreatic adenocarcinoma patients using next-generation sequencing. [PDF]
Marin AM +11 more
europepmc +1 more source

